Temporary position, anticipated to extend until September 7, 2026, subject to the availability of work.
Five-year contract position, including health benefits and a pension program, with the expectation for renewal.
The Lawson Health Research Institute is one of Canada’s largest and most respected hospital-based research institutes. As the research institute of St. Joseph’s Health Care London and London Health Sciences Centre, and working in partnership with Western University, Lawson is committed to furthering scientific knowledge to advance health care around the world and to helping people live healthier lives by enhancing our knowledge of preventing, diagnosing, and treating disease.
Lawson is seeking a Staff Radiochemist for its Cyclotron and Radiochemistry Facility in London, Ontario.
The Radiochemist will become a key part of a research/clinical team in an academic hospital environment and report to Dr. Michael Kovacs, Director of the Lawson Cyclotron & Radiochemistry Facility at St. Joseph’s Hospital. This facility uses a medical cyclotron to produce radioisotopes for Positron Emission Tomography (PET) imaging, enabling early and accurate detection of cancer and diseases of the heart and brain. Lawson collaborates and performs radiopharmaceutical research and development work with scientists, clinicians, and academic and commercial partners.
The Radiochemist will oversee and implement the development, production and synthesis of radioisotopes and radiopharmaceuticals using the ARTMS QUANTM Irradiation System solid target hardware, customized cyclotron solid targets and proprietary processes in order to meet current and future radiopharmaceutical product objectives. The primary focus of the Radiochemist will be to lead the completion of project objectives performed as part of a collaboration between Lawson and ARTMS Inc, the global leader in cyclotron solid targetry.
The position is part of a team surpassing current cyclotron-based isotope manufacturing and processing capabilities and changing the practice of nuclear medicine. The Radiochemist will work on the next generation of radiopharmaceutical products, including cyclotron production of gallium-68, zirconium-89, copper-64 and possibly other metallic radionuclides which will be used to label radiopharmaceutical precursors for eventual clinical and commercial activities.
The primary focus of the Radiochemist is to ensure that (i) radiopharmaceutical product specifications meet ARTMS, industry and end-user expectations and (ii) operations, workflow and end products are compliant with relevant certifications, in-house QC/QA standards and regulatory authority requirements. An additional focus is to produce and maintain accurate and up-todate documentation on product manufacturing processes currently in development or in the pre-commercialization stage.
The position is essential to the success of novel production methods for metallic isotopes such as Ga-68, Zr-89 and Cu-64. The position will also be important for completing the study of new radiopharmaceuticals and the implementation of improved techniques and procedures for eventual clinical trials and commercialization activities.
In addition, the Radiochemist will have the opportunity to explore novel research, publication and presentation efforts in collaboration with colleagues.
For more information, please see the full posting. To apply, please visit the St. Joseph’s Health Care London Careers website (Job ID: 45521)
